Literature DB >> 22861906

Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1.

Marie Douniol1, Aurélia Jacquette, David Cohen, Nicolas Bodeau, Linda Rachidi, Nathalie Angeard, Jean-Marie Cuisset, Louis Vallée, Bruno Eymard, Monique Plaza, Delphine Héron, Jean-Marc Guilé.   

Abstract

AIM: To investigate the psychiatric and cognitive phenotype in young individuals with the childhood form of myotonic dystrophy type 1 (DM1).
METHOD: Twenty-eight individuals (15 females, 13 males) with childhood DM1 (mean age 17y, SD 4.6, range 7-24y) were assessed using standardized instruments and cognitive testing of general intelligence, visual attention, and visual-spatial construction abilities.
RESULTS: Nineteen patients had repeated a school grade. The mean (SD) Full-scale IQ was 73.6 (17.5) and mean Verbal IQ was significantly higher than the mean Performance IQ: 80.2 (19.22) versus 72.95 (15.58), p=0.01. Fifteen patients had one or more diagnoses on the DSM-IV axis 1, including internalizing disorders (phobia, n=7; mood disorder, n=6; other anxiety disorders, n=5) and attention-deficit-hyperactivity disorder, inattentive subtype (n=8). Twelve out of 22 patients had alexithymia (inability to express feelings with words and to recognize and share emotional states). Cognitive testing found severe impairments in visual attention and visual-spatial construction abilities in four out of 18, and 14 out of 24 patients respectively. No diagnosis was correlated with the transmitting parent's sex or with cytosine-thymine-guanine (CTG) repeat numbers. Patients with severe visual-spatial construction disabilities had a significantly longer CTG expansion size than those with normal visual-spatial abilities (p=0.04).
INTERPRETATION: Children and adolescents with childhood DM1 have frequent diagnoses on DSM-IV axis 1, with internalizing disorders being the most common type of disorder. They also have borderline low intelligence and frequent impairments in attention and visual-spatial construction abilities. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 22861906     DOI: 10.1111/j.1469-8749.2012.04379.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  24 in total

1.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

Review 2.  Myotonic dystrophy.

Authors:  Charles A Thornton
Journal:  Neurol Clin       Date:  2014-06-06       Impact factor: 3.806

3.  An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation.

Authors:  Emma Koehorst; Renato Odria; Júlia Capó; Judit Núñez-Manchón; Andrea Arbex; Miriam Almendrote; Ian Linares-Pardo; Daniel Natera-de Benito; Verónica Saez; Andrés Nascimento; Carlos Ortez; Miguel Ángel Rubio; Jordi Díaz-Manera; Jorge Alonso-Pérez; Giuseppe Lucente; Agustín Rodriguez-Palmero; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Gisela Nogales-Gadea; Mònica Suelves
Journal:  Biomedicines       Date:  2022-06-10

4.  Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.

Authors:  Qing Liu; Yu-Fei Zheng; Yan-Ping Zhu; Shi-Qing Ling; Wei-Rong Li
Journal:  Exp Ther Med       Date:  2015-09-09       Impact factor: 2.447

Review 5.  Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Authors:  Seren Marsh; Britt Hanson; Matthew J A Wood; Miguel A Varela; Thomas C Roberts
Journal:  Mol Ther       Date:  2020-10-14       Impact factor: 11.454

Review 6.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

7.  Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).

Authors:  Stéphane Jean; Louis Richer; Luc Laberge; Jean Mathieu
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

8.  Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage.

Authors:  Francesca Caso; Federica Agosta; Stojan Peric; Vidosava Rakočević-Stojanović; Massimiliano Copetti; Vladimir S Kostic; Massimo Filippi
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

9.  Cognitive function and its relationship with brain structure in myotonic dystrophy type 1.

Authors:  Kathleen E Langbehn; Ellen van der Plas; David J Moser; Jeffrey D Long; Laurie Gutmann; Peggy C Nopoulos
Journal:  J Neurosci Res       Date:  2020-02-13       Impact factor: 4.164

10.  Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1.

Authors:  Laura Serra; Matteo Mancini; Gabriella Silvestri; Antonio Petrucci; Marcella Masciullo; Barbara Spanò; Mario Torso; Chiara Mastropasqua; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Giovanni Meola; Marco Bozzali
Journal:  Neural Plast       Date:  2016-05-25       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.